View in EDS

Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study.

Saved in:
Bibliographic Details
Title: Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study.
Authors: Topp MS; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Matasar M; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ., Allan JN; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY., Ansell SM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Barnes JA; Department of Medicine, Hematology and Oncology Division, Massachusetts General Hospital Cancer Center, Boston, MA., Arnason JE; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA., Michot JM; Departement D'Innovation Therapeutique et D'Essais Precoces, Gustave Roussy Cancer Campus, Villejuif, France., Goldschmidt N; Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., O'Brien SM; Division of Hematology/Oncology, Department of Medicine, Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, Orange, CA., Abadi U; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Department of Hematology, Meir Medical Center, Kfar Saba, Israel., Avivi I; Department of Hematology, Ichilov University Hospital, Tel Aviv, Israel., Cheng Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Flink DM; Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Zhu M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Brouwer-Visser J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Chaudhry A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Mohamed H; Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Ambati S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Crombie JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Source: Blood [Blood] 2025 Apr 03; Vol. 145 (14), pp. 1498-1509.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39786390
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Topp+MS%22">Topp MS</searchLink>; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Matasar+M%22">Matasar M</searchLink>; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ.<br /><searchLink fieldCode="AU" term="%22Allan+JN%22">Allan JN</searchLink>; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY.<br /><searchLink fieldCode="AU" term="%22Ansell+SM%22">Ansell SM</searchLink>; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Barnes+JA%22">Barnes JA</searchLink>; Department of Medicine, Hematology and Oncology Division, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Arnason+JE%22">Arnason JE</searchLink>; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Michot+JM%22">Michot JM</searchLink>; Departement D'Innovation Therapeutique et D'Essais Precoces, Gustave Roussy Cancer Campus, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Goldschmidt+N%22">Goldschmidt N</searchLink>; Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22O'Brien+SM%22">O'Brien SM</searchLink>; Division of Hematology/Oncology, Department of Medicine, Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, Orange, CA.<br /><searchLink fieldCode="AU" term="%22Abadi+U%22">Abadi U</searchLink>; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Department of Hematology, Meir Medical Center, Kfar Saba, Israel.<br /><searchLink fieldCode="AU" term="%22Avivi+I%22">Avivi I</searchLink>; Department of Hematology, Ichilov University Hospital, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Cheng+Y%22">Cheng Y</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.<br /><searchLink fieldCode="AU" term="%22Flink+DM%22">Flink DM</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.<br /><searchLink fieldCode="AU" term="%22Zhu+M%22">Zhu M</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.<br /><searchLink fieldCode="AU" term="%22Brouwer-Visser+J%22">Brouwer-Visser J</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.<br /><searchLink fieldCode="AU" term="%22Chaudhry+A%22">Chaudhry A</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.<br /><searchLink fieldCode="AU" term="%22Mohamed+H%22">Mohamed H</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.<br /><searchLink fieldCode="AU" term="%22Ambati+S%22">Ambati S</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.<br /><searchLink fieldCode="AU" term="%22Crombie+JL%22">Crombie JL</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2025 Apr 03; Vol. 145 (14), pp. 1498-1509.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39786390
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood.2024027044
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1498
    Titles:
      – TitleFull: Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Topp MS
      – PersonEntity:
          Name:
            NameFull: Matasar M
      – PersonEntity:
          Name:
            NameFull: Allan JN
      – PersonEntity:
          Name:
            NameFull: Ansell SM
      – PersonEntity:
          Name:
            NameFull: Barnes JA
      – PersonEntity:
          Name:
            NameFull: Arnason JE
      – PersonEntity:
          Name:
            NameFull: Michot JM
      – PersonEntity:
          Name:
            NameFull: Goldschmidt N
      – PersonEntity:
          Name:
            NameFull: O'Brien SM
      – PersonEntity:
          Name:
            NameFull: Abadi U
      – PersonEntity:
          Name:
            NameFull: Avivi I
      – PersonEntity:
          Name:
            NameFull: Cheng Y
      – PersonEntity:
          Name:
            NameFull: Flink DM
      – PersonEntity:
          Name:
            NameFull: Zhu M
      – PersonEntity:
          Name:
            NameFull: Brouwer-Visser J
      – PersonEntity:
          Name:
            NameFull: Chaudhry A
      – PersonEntity:
          Name:
            NameFull: Mohamed H
      – PersonEntity:
          Name:
            NameFull: Ambati S
      – PersonEntity:
          Name:
            NameFull: Crombie JL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 04
              Text: 2025 Apr 03
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Numbering:
            – Type: volume
              Value: 145
            – Type: issue
              Value: 14
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1